SOAN
Price:
$0.06834
Market Cap:
$0
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
Industry
Biotechnology
IPO Date
2022-01-31
Stock Exchange
OTC
Ticker
SOAN
According to AngioSoma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -22.78. This represents a change of -99.48% compared to the average of -4410.73 of the last 4 quarters.
The mean historical PE Ratio of AngioSoma, Inc. over the last ten years is -5.05. The current -22.78 PE Ratio has changed 45.03% with respect to the historical average. Over the past ten years (40 quarters), SOAN's PE Ratio was at its highest in in the June 2016 quarter at 0.41. The PE Ratio was at its lowest in in the September 2020 quarter at -17584.78.
Average
-5.05
Median
-0.41
Minimum
-37.60
Maximum
-0.00
Discovering the peaks and valleys of AngioSoma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.18%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -96.16%
Minimum Annual PE Ratio = -37.60
| Year | PE Ratio | Change |
|---|---|---|
| 2020 | -37.60 | 557.30% |
| 2019 | -5.72 | 20.99% |
| 2018 | -4.73 | 198.24% |
| 2017 | -1.59 | 204.89% |
| 2016 | -0.52 | 73.87% |
| 2015 | -0.30 | 3.18% |
| 2014 | -0.01 | 59.74% |
| 2013 | -0.01 | 870.80% |
| 2012 | -0.00 | -89.67% |
| 2011 | -0.01 | -96.16% |
The current PE Ratio of AngioSoma, Inc. (SOAN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-16.02
5-year avg
-10.03
10-year avg
-5.05
AngioSoma, Inc.’s PE Ratio is less than LakeShore Biopharma Co., Ltd (-6.19), less than IntelGenx Technologies Corp. (-2.99), less than Alpha Cognition Inc. (-8.68), less than ImmuPharma plc (-7.39), less than Small Pharma Inc. (-2.17), less than IBEX Technologies Inc. (9.23), less than Pharmaxis Ltd (-1.62), less than OKYO Pharma Limited (-17.45), less than Kadimastem Ltd (-1.94), less than Enzo Biochem, Inc. (-1.74),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.19 | $33.79M | |
| -2.99 | $29.69M | |
| -8.68 | $35.66M | |
| -7.39 | $28.34M | |
| -2.17 | $37.51M | |
| 9.23 | $25.27M | |
| -1.62 | $31.04M | |
| -17.45 | $22.73M | |
| -1.94 | $9.50M | |
| -1.74 | $36.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AngioSoma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AngioSoma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AngioSoma, Inc.'s PE Ratio?
How is the PE Ratio calculated for AngioSoma, Inc. (SOAN)?
What is the highest PE Ratio for AngioSoma, Inc. (SOAN)?
What is the 3-year average PE Ratio for AngioSoma, Inc. (SOAN)?
What is the 5-year average PE Ratio for AngioSoma, Inc. (SOAN)?
How does the current PE Ratio for AngioSoma, Inc. (SOAN) compare to its historical average?